NCT00012350View on ClinicalTrials.gov

Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

September 30, 2003

Study Completion Date

January 31, 2010

Conditions
Multiple Myeloma
Interventions
DRUG

FTI

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT00012350 - Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma | Biotech Hunter | Biotech Hunter